Pill for thought: Sweetheart deals that hurt consumers

Preserving competition in the pharmaceutical sector is sure to make a real difference to people's lives, notes Vaibhav Choukse. India is among the world's fastest-growing pharma markets, accounting......

Time for Indian pharma cos to change strategies

It's time for Indian generic companies to rethink their strategies, says Bhupesh Bhandari. In July, the European Commission imposed fines of euro 427.7 million on Servier of France and five......

Ranbaxy, Daiichi Sankyo to leverage synergies

Drug firm Ranbaxy Laboratories and its Japanese parent Daiichi Sankyo will integrate their business operations in Thailand as part of strategy to maximise synergies.Both the companies intend to......

Pharma firms spend 10% of production cost on tie-ups

Leading pharmaceutical companies are now making serious attempts to tie up with technology partners to enable their consumers identify genuine products in the market. Drug makers such as Ranbaxy......